Filter announcements
Loading...
Incorporated in 1994, Medico Remedies Ltd manufactures and sells pharmaceutical formulations
MEDICO Remedies announced a book closure period for its 32nd Annual General Meeting. The company's Equity Paid-Up Capital stands at 16.60 Cr.
Medico Remedies Limited has informed the Exchange regarding Notice of undefined to be held on September 22, 2026
Medico's board approved Q1 financial results. Revenue hit ₹69.40 Cr, with profit at ₹2.52 Cr. The board also re-appointed Rishit Mehta and Haresh Mehta as Whole-Time Directors and increased MD Harshit Mehta's remuneration.
Medico Remedies secured a government order worth ₹13.38 Cr from PROMESE/CAL, Dominican Republic. The contract involves supplying tablets, capsules, and dry syrups, with full execution expected within 3 months.
Medico Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015